IL-8, 149 ileum, 278 imbalances, 54, 55, 59, 60, 61, 62, 63, 65 immersion, 319 immigrants, 53 immune cells, 8 immune response, ix, 1, 7, 18, 21, 35, 307 immune system, 35, 108, 190, 333 immunity, 45, 316 immunoglobulin, 162 immunoglobulins, 162 immunohistochemical, 159 immunological, 39, 297, 298, 299, 300, 302, 305 immunology, 37 immunomodulatory, 10, 301 immunomodulatory agent, 10 immunomodulatory agents, 10 immunopathology, 37 immunostimulatory, 300 immunosuppression, 11 immunosuppressive, xiii, 160, 243, 276 impurities, 62, 283 IMS, 136 in situ, 21, 52, 53, 58, 83, 84, 85, 229 in vivo, xiii, 7, 8, 17, 34, 38, 43, 128, 148, 150, 153, 159, 160, 163, 164, 176, 177, 178, 181, 230, 233, 234, 235, 243, 320 inactivation, 152, 320, 326 inactive, 317, 326, 330 incidence, xi, 6, 7, 10, 11, 15, 16, 17, 21, 22, 23, 24, 26, 27, 29, 34, 35, 37, 38, 39, 41, 45, 167, 168, 184, 190, 198, 330 inclusion, 236 income, 168 incubation, 143, 149, 249, 293, 317, 318, 319 incubation period, 317, 319 indicators, x, xiv, 49, 58, 62, 279, 318, 332 indigenous, 50, 51, 52, 53, 55, 66, 306, 316 indigenous knowledge, 53 indomethacin, 101, 102, 103, 104, 108, 109, 112, 113, 116, 123, 124, 125, 128, 129, 133, 134, 137, 150 inducible enzyme, 19 induction, 19, 20, 44, 102, 108, 111, 131, 142, 161, 163 industrial, 86 industry, xiv, 263, 267, 271, 275 inert, 66, 293 infancy, 213, 216 infant mortality, 14, 15, 44 <strong>Index</strong> 351 infants, 15, 44, 190, 198, 212, 213 infection, xii, 3, 15, 37, 45, 63, 143, 149, 158, 162, 189, 190, 191, 319, 323, 331 infections, ix, xi, 15, 105, 139, 140, 157, 191, 199, 223, 324 infectious, xii, 15, 74, 189, 191, 316, 323, 330 infectious disease, 323 infectious diseases, 191, 316, 330 inferences, 12 infertility, 211 inflammation, ix, xi, 4, 22, 42, 45, 59, 60, 98, 104, 111, 112, 123, 130, 131, 132, 133, 139, 140, 149, 157, 165, 167, 222, 223, 229, 236, 238, 280 inflammatory cells, 104 inflammatory mediators, 7, 98 inflammatory response, 16, 17, 18, 20, 41, 42 informed consent, 15 infrared, ix, 145, 256, 257, 313 infrared spectroscopy, ix, 256, 257, 313 infusions, 68, 69 ingestion, 67, 98, 172, 174, 232, 235 inherited, 64 inhibitor, 7, 20, 43, 101, 102, 103, 105, 106, 107, 109, 111, 116, 129, 136, 137, 150, 158, 171, 175, 176, 178, 180, 184, 185, 186, 196, 263, 328, 335, 336 inhibitors, xv, 11, 19, 44, 102, 113, 114, 135, 137, 162, 169, 170, 174, 178, 181, 183, 185, 186, 315, 316, 326, 328, 329, 333 inhibitory effect, 7, 17, 19, 104, 123, 149, 160, 165, 174, 181, 183, 186, 187, 192, 316, 324, 329 initiation, 22, 182 injection, 108, 149, 237 injections, 65, 169 injuries, 63, 126, 162, 223, 230, 231, 232, 233, 263 injury, x, 46, 97, 98, 99, 100, 101, 102, 104, 105, 106, 107, 108, 109, 111, 112, 113, 114, 115, 123, 124, 126, 127, 128, 133, 134, 135, 148, 165, 166, 220, 237, 281, 307 inoculation, 142, 143 inorganic, 21 iNOS, 7, 104, 105, 149, 155, 160 inositol, 305 insecticide, 218 insecticides, 225 insects, 218, 220, 244, 316, 336 insemination, 250 insertion, 105 insight, 234 insomnia, 64
352 institutions, 84 instruments, 291 insulin, ix, xi, 12, 13, 41, 167, 168, 169, 170, 171, 172, 173, 174, 175, 177, 180, 182, 183, 187 insulin resistance, 12, 13, 168, 175 insulin sensitivity, 168, 180, 187 integration, 143 integrity, 51, 98, 100, 104, 110, 128 intensity, 283 interaction, 5, 10, 11, 28, 29, 32, 38, 47, 129, 153, 193, 257, 276, 331 interactions, 32, 104, 105, 130, 157, 218, 278, 323, 333 intercellular adhesion molecule, 109 interdisciplinary, 51 interface, 133 interference, 173, 206, 312 interferons, 152 intergenerational, 51 interleukin, 108, 132, 134, 149, 152, 166 interleukin-1, 132 interleukin-2, 134 interleukin-8, 149, 166 internet, 85, 86 inter-population, 84 interrelations, 270 interstitial, 229, 231 intervention, ix, 1, 5, 9, 10, 19, 22, 25, 27, 29, 31, 35, 36, 41, 42, 46, 65, 336 intervention strategies, 336 interviews, 28, 29, 56, 61 intestine, 175 intoxication, 64, 75, 228, 229, 230, 231, 232, 239 intraperitoneal, 105, 248 intrauterine growth retardation, 211 intravenous, 248, 249 intravenously, 249 intravital microscopy, 112 intrinsic, 16, 301, 316, 327 intrinsic viscosity, 301 invasive, xiii, 18, 220, 255, 256, 257 invasive cancer, 18 investigations, 197 investment, ix, xiii, xiv, 275 iodine, xii, 203, 210, 211, 215 ionic, 144, 212, 293, 303, 306, 310 ionization, 286, 287, 291, 295, 303, 309, 310 ions, 99, 145, 291, 322 iron, xii, 148, 203, 211, 213 iron deficiency, 211 <strong>Index</strong> irradiation, 46, 205, 206, 207 irradiations, 206 irritability, 64, 72, 231 ischaemia, 135 ischemia, 99, 112, 148 ischemic, 5, 38, 155, 159 ischemic brain injury, 155, 159 ischemic heart disease, 5, 38 isoelectric point, 175 isoenzymes, 102, 128 is<strong>of</strong>orms, 103, 114, 175 isolation, 162, 166, 169, 179, 191, 193, 194, 195, 199, 217, 284, 300, 301, 302, 309, 331, 332, 334 isomers, 2, 3, 292, 311 isoniazid, 190, 193, 196 isoprene, 3, 114, 135, 324 isorhamnetin, 220 isotope, 215 isozymes, 129 IUCN, 90, 95 JAMA, 35, 38, 41, 47 Jatropha, 115, 124, 136 jaundice, 232 Jun, 107, 183, 187 Jung, 159, 161, 182, 308 K + , 99, 106 kappa B, 149, 154, 165, 166 KBr, 291, 295 keratinocytes, 2, 45 kernel, 178, 185 kerosene, 66 kidney, 64, 168, 175, 184, 236, 250 kidney failure, 168 kidneys, 59, 64, 168, 190, 229, 249 kinase, 19, 107, 150, 152, 160, 177, 185, 297 kinase activity, 150 kinetic model, 142 kinetics, 9, 36 knockout, 19, 43, 108 KOH, 283, 286 J K
- Page 2 and 3:
BIOTECHNOLOGY IN AGRICULTURE, INDUS
- Page 4:
Industrial Biotechnology Shara L. A
- Page 7 and 8:
Copyright © 2009 by Nova Science P
- Page 9 and 10:
viii Contents Chapter 8 Pharmacolog
- Page 11 and 12:
x Alejandro Varela and Jasiah Ibañ
- Page 13 and 14:
xii Alejandro Varela and Jasiah Iba
- Page 15 and 16:
xiv Alejandro Varela and Jasiah Iba
- Page 18 and 19:
In: Medicinal Plants: Classificatio
- Page 20 and 21:
Biological Effects of -Carotene acy
- Page 22 and 23:
Biological Effects of -Carotene cry
- Page 24 and 25:
Biological Effects of -Carotene ris
- Page 26 and 27:
Biological Effects of -Carotene Whe
- Page 28 and 29:
Biological Effects of -Carotene fla
- Page 30 and 31:
Biological Effects of -Carotene Pre
- Page 32 and 33:
Biological Effects of -Carotene A (
- Page 34 and 35:
Biological Effects of -Carotene As
- Page 36 and 37:
Biological Effects of -Carotene car
- Page 38 and 39:
Biological Effects of -Carotene res
- Page 40 and 41:
Biological Effects of -Carotene the
- Page 42 and 43:
Biological Effects of -Carotene cat
- Page 44 and 45:
Biological Effects of -Carotene mos
- Page 46 and 47:
Biological Effects of -Carotene dia
- Page 48 and 49:
Biological Effects of -Carotene veg
- Page 50 and 51:
Biological Effects of -Carotene .Su
- Page 52 and 53:
Biological Effects of -Carotene Bat
- Page 54 and 55:
Biological Effects of -Carotene Dah
- Page 56 and 57:
Biological Effects of -Carotene Hal
- Page 58 and 59:
Biological Effects of -Carotene Kva
- Page 60 and 61:
Biological Effects of -Carotene Osh
- Page 62 and 63:
Biological Effects of -Carotene San
- Page 64:
Biological Effects of -Carotene Van
- Page 67 and 68:
50 Gustavo J. Martínez, Mara Sato
- Page 69 and 70:
52 Gustavo J. Martínez, Mara Sato
- Page 71 and 72:
54 Gustavo J. Martínez, Mara Sato
- Page 73 and 74:
56 Gustavo J. Martínez, Mara Sato
- Page 75 and 76:
58 [2] Gustavo J. Martínez, Mara S
- Page 77 and 78:
60 Gustavo J. Martínez, Mara Sato
- Page 79 and 80:
62 Gustavo J. Martínez, Mara Sato
- Page 81 and 82:
64 Gustavo J. Martínez, Mara Sato
- Page 83 and 84:
66 Gustavo J. Martínez, Mara Sato
- Page 85 and 86:
68 Gustavo J. Martínez, Mara Sato
- Page 87 and 88:
70 Gustavo J. Martínez, Mara Sato
- Page 89 and 90:
Huperzia saururus (Lam.) Trevis. Mi
- Page 91 and 92:
74 Gustavo J. Martínez, Mara Sato
- Page 93 and 94:
76 Gustavo J. Martínez, Mara Sato
- Page 95 and 96:
PNEUMONOLOGY AND INFECTIOUS DISEASE
- Page 97 and 98:
80 Gustavo J. Martínez, Mara Sato
- Page 99 and 100:
82 Gustavo J. Martínez, Mara Sato
- Page 101 and 102:
84 Gustavo J. Martínez, Mara Sato
- Page 103 and 104:
86 Gustavo J. Martínez, Mara Sato
- Page 105 and 106:
88 Gustavo J. Martínez, Mara Sato
- Page 107 and 108:
90 Gustavo J. Martínez, Mara Sato
- Page 109 and 110:
92 Gustavo J. Martínez, Mara Sato
- Page 111 and 112:
94 Gustavo J. Martínez, Mara Sato
- Page 113 and 114:
96 Gustavo J. Martínez, Mara Sato
- Page 115 and 116:
98 Aracely E. Chávez-Piña and And
- Page 117 and 118:
100 Aracely E. Chávez-Piña and An
- Page 119 and 120:
102 Aracely E. Chávez-Piña and An
- Page 121 and 122:
104 Aracely E. Chávez-Piña and An
- Page 123 and 124:
106 Aracely E. Chávez-Piña and An
- Page 125 and 126:
108 Aracely E. Chávez-Piña and An
- Page 127 and 128:
110 Aracely E. Chávez-Piña and An
- Page 129 and 130:
112 Aracely E. Chávez-Piña and An
- Page 131 and 132:
114 Aracely E. Chávez-Piña and An
- Page 133 and 134:
116 Aracely E. Chávez-Piña and An
- Page 135 and 136:
118 HO HO HO HO HO HO OH OH M e Me
- Page 137 and 138:
120 Me Me OH Me O OH O O OH H Me OH
- Page 139 and 140:
122 HO HO HO Aracely E. Chávez-Pi
- Page 141 and 142:
124 Aracely E. Chávez-Piña and An
- Page 143 and 144:
126 Aracely E. Chávez-Piña and An
- Page 145 and 146:
128 Aracely E. Chávez-Piña and An
- Page 147 and 148:
130 Aracely E. Chávez-Piña and An
- Page 149 and 150:
132 Aracely E. Chávez-Piña and An
- Page 151 and 152:
134 Aracely E. Chávez-Piña and An
- Page 153 and 154:
136 Aracely E. Chávez-Piña and An
- Page 155 and 156:
138 Aracely E. Chávez-Piña and An
- Page 157 and 158:
140 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 159 and 160:
142 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 161 and 162:
144 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 163 and 164:
146 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 165 and 166:
148 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 167 and 168:
150 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 169 and 170:
152 6.4. Antibacterial Effects Hua-
- Page 171 and 172:
154 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 173 and 174:
156 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 175 and 176:
158 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 177 and 178:
160 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 179 and 180:
162 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 181 and 182:
164 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 183 and 184:
166 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 185 and 186:
168 Vandana Gulati, Ian H. Harding
- Page 187 and 188:
170 Vandana Gulati, Ian H. Harding
- Page 189 and 190:
172 Vandana Gulati, Ian H. Harding
- Page 191 and 192:
174 Vandana Gulati, Ian H. Harding
- Page 193 and 194:
176 Vandana Gulati, Ian H. Harding
- Page 195 and 196:
178 Vandana Gulati, Ian H. Harding
- Page 197 and 198:
180 Vandana Gulati, Ian H. Harding
- Page 199 and 200:
182 Vandana Gulati, Ian H. Harding
- Page 201 and 202:
184 Vandana Gulati, Ian H. Harding
- Page 203 and 204:
186 Vandana Gulati, Ian H. Harding
- Page 206 and 207:
In: Medicinal Plants: Classificatio
- Page 208 and 209:
Biomolecules with Anti-Mycobacteria
- Page 210 and 211:
Biomolecules with Anti-Mycobacteria
- Page 212 and 213:
Biomolecules with Anti-Mycobacteria
- Page 214 and 215:
Biomolecules with Anti-Mycobacteria
- Page 216 and 217:
Biomolecules with Anti-Mycobacteria
- Page 218:
Biomolecules with Anti-Mycobacteria
- Page 221 and 222:
204 Chien-Yi Chen Ligusticum chuanx
- Page 223 and 224:
206 Chien-Yi Chen (IAEA 336), also
- Page 225 and 226:
208 Chien-Yi Chen 4. Results and Di
- Page 227 and 228:
210 4.3. Fresh Leaves and Stems Chi
- Page 229 and 230:
212 Chien-Yi Chen collected from na
- Page 231 and 232:
214 Chien-Yi Chen primary enzyme in
- Page 233 and 234:
216 Chien-Yi Chen [20] Liu SM, Chun
- Page 235 and 236:
218 S.M.M. Vasconcelos, J.E.R. Hon
- Page 237 and 238:
220 S.M.M. Vasconcelos, J.E.R. Hon
- Page 239 and 240:
222 S.M.M. Vasconcelos, J.E.R. Hon
- Page 241 and 242:
224 S.M.M. Vasconcelos, J.E.R. Hon
- Page 243 and 244:
226 S.M.M. Vasconcelos, J.E.R. Hon
- Page 245 and 246:
228 S.M.M. Vasconcelos, J.E.R. Hon
- Page 247 and 248:
230 S.M.M. Vasconcelos, J.E.R. Hon
- Page 249 and 250:
232 S.M.M. Vasconcelos, J.E.R. Hon
- Page 251 and 252:
234 S.M.M. Vasconcelos, J.E.R. Hon
- Page 253 and 254:
236 S.M.M. Vasconcelos, J.E.R. Hon
- Page 255 and 256:
238 S.M.M. Vasconcelos, J.E.R. Hon
- Page 257 and 258:
240 S.M.M. Vasconcelos, J.E.R. Hon
- Page 259 and 260:
242 S.M.M. Vasconcelos, J.E.R. Hon
- Page 261 and 262:
244 Sônia Sin Singer Brugiolo, Luc
- Page 263 and 264:
246 Sônia Sin Singer Brugiolo, Luc
- Page 265 and 266:
248 Sônia Sin Singer Brugiolo, Luc
- Page 267 and 268:
250 Sônia Sin Singer Brugiolo, Luc
- Page 269 and 270:
252 Sônia Sin Singer Brugiolo, Luc
- Page 271 and 272:
254 Sônia Sin Singer Brugiolo, Luc
- Page 273 and 274:
256 C.W. Huck and G.K. Bonn Keyword
- Page 275 and 276:
258 C.W. Huck and G.K. Bonn No addi
- Page 277 and 278:
260 C.W. Huck and G.K. Bonn The rob
- Page 279 and 280:
262 C.W. Huck and G.K. Bonn Validat
- Page 281 and 282:
264 Naphthodianthrones C.W. Huck an
- Page 283 and 284:
266 C.W. Huck and G.K. Bonn Figure
- Page 285 and 286:
268 C.W. Huck and G.K. Bonn Figure
- Page 287 and 288:
270 C.W. Huck and G.K. Bonn hierarc
- Page 289 and 290:
272 C.W. Huck and G.K. Bonn [17] Hu
- Page 292 and 293:
In: Medicinal Plants Classification
- Page 294 and 295:
What is the Future of Phytotherapy?
- Page 296 and 297:
In: Medicinal Plants Classification
- Page 298 and 299:
Quality Control of Polysaccharides
- Page 300 and 301:
Quality Control of Polysaccharides
- Page 302 and 303:
Quality Control of Polysaccharides
- Page 304 and 305:
Quality Control of Polysaccharides
- Page 306 and 307:
Quality Control of Polysaccharides
- Page 308 and 309:
Quality Control of Polysaccharides
- Page 310 and 311:
Quality Control of Polysaccharides
- Page 312 and 313:
Origins Targets Neisseria meningiti
- Page 314 and 315:
Quality Control of Polysaccharides
- Page 316 and 317:
Quality Control of Polysaccharides
- Page 318 and 319: Quality Control of Polysaccharides
- Page 320 and 321: Quality Control of Polysaccharides
- Page 322 and 323: Quality Control of Polysaccharides
- Page 324 and 325: Quality Control of Polysaccharides
- Page 326 and 327: Quality Control of Polysaccharides
- Page 328 and 329: Quality Control of Polysaccharides
- Page 330: Quality Control of Polysaccharides
- Page 333 and 334: 316 Philippe N. Okusa, Caroline Ste
- Page 335 and 336: 318 Philippe N. Okusa, Caroline Ste
- Page 337 and 338: 320 2.7. General Toxicity Tests Phi
- Page 339 and 340: 322 Philippe N. Okusa, Caroline Ste
- Page 341 and 342: 324 Philippe N. Okusa, Caroline Ste
- Page 343 and 344: 326 Philippe N. Okusa, Caroline Ste
- Page 345 and 346: 328 Philippe N. Okusa, Caroline Ste
- Page 347 and 348: 330 Philippe N. Okusa, Caroline Ste
- Page 349 and 350: 332 Philippe N. Okusa, Caroline Ste
- Page 351 and 352: 334 Philippe N. Okusa, Caroline Ste
- Page 353 and 354: 336 Philippe N. Okusa, Caroline Ste
- Page 355 and 356: 338 age-related macular degeneratio
- Page 357 and 358: 340 B lymphocytes, 7 babies, 60, 62
- Page 359 and 360: 342 cell surface, 229 cellular adhe
- Page 361 and 362: 344 cultivation, 75, 76, 83, 85, 14
- Page 363 and 364: 346 embryonic stem cells, 47 emotio
- Page 365 and 366: 348 gas, xiii, 21, 104, 131, 145, 1
- Page 367: 350 high-performance liquid chromat
- Page 371 and 372: 354 lung, ix, 1, 6, 16, 17, 22, 23,
- Page 373 and 374: 356 mucosa, x, 2, 19, 97, 98, 99, 1
- Page 375 and 376: 358 oxidative, 4, 8, 9, 10, 12, 13,
- Page 377 and 378: 360 polyunsaturated fatty acids, 10
- Page 379 and 380: 362 Reserpine, 328 reservation, 143
- Page 381 and 382: 364 SPT, 135 squamous cell carcinom
- Page 383 and 384: 366 transcription, 8, 35, 152 trans